日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity

BCL2表达在具有谱系可塑性特征的晚期前列腺癌中富集

Westaby, Daniel; Jiménez-Vacas, Juan M; Figueiredo, Ines; Rekowski, Jan; Pettinger, Claire; Gurel, Bora; Lundberg, Arian; Bogdan, Denisa; Buroni, Lorenzo; Neeb, Antje; Padilha, Ana; Taylor, Joe; Zeng, Wanting; Das, Souvik; Hobern, Emily; Riisnaes, Ruth; Crespo, Mateus; Miranda, Susana; Ferreira, Ana; Hanratty, Brian P; Nava Rodrigues, Daniel; Bertan, Claudia; Seed, George; Fenor de La Maza, Maria de Los Dolores; Guo, Christina; Carmichael, Juliet; Grochot, Rafael; Chandran, Khobe; Stavridi, Anastasia; Varkaris, Andreas; Stylianou, Nataly; Hollier, Brett G; Tunariu, Nina; Balk, Steven P; Carreira, Suzanne; Yuan, Wei; Nelson, Peter S; Corey, Eva; Haffner, Michael; de Bono, Johann; Sharp, Adam

Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate Cancer

Thio-2 抑制去势抵抗性前列腺癌发展和进展所需的关键信号通路

Antje Neeb, Ines Figueiredo, Denisa Bogdan, Laura Cato, Jutta Stober, Juan M Jiménez-Vacas, Victor Gourain, Irene I Lee, Rebecca Seeger, Claudia Muhle-Goll, Bora Gurel, Jonathan Welti, Daniel Nava Rodrigues, Jan Rekowski, Xintao Qiu, Yija Jiang, Patrizio Di Micco, Borja Mateos, Stasė Bielskutė, Ruth

Systematic study of tissue factor expression in solid tumors

实体肿瘤中组织因子表达的系统研究

Johann S de Bono, Jeffrey R Harris, Saskia M Burm, Adriaan Vanderstichele, Mischa A Houtkamp, Saida Aarass, Ruth Riisnaes, Ines Figueiredo, Daniel Nava Rodrigues, Rossitza Christova, Siel Olbrecht, Hans W M Niessen, Sigrid R Ruuls, Danita H Schuurhuis, Jeroen J Lammerts van Bueren, Esther C W Breij,

Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

评估雄激素受体剪接变体-7 作为去势敏感性前列腺癌临床反应的生物标志物

Adam G Sowalsky, Ines Figueiredo, Rosina T Lis, Ilsa Coleman, Bora Gurel, Denisa Bogdan, Wei Yuan, Joshua W Russo, John R Bright, Nichelle C Whitlock, Shana Y Trostel, Anson T Ku, Radhika A Patel, Lawrence D True, Jonathan Welti, Juan M Jimenez-Vacas, Daniel Nava Rodrigues, Ruth Riisnaes, Antje Neeb

JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer

JMJD6 是一种可用于药物的加氧酶,可调节前列腺癌中的 AR-V7 表达

Alec Paschalis #, Jonathan Welti #, Antje J Neeb, Wei Yuan, Ines Figueiredo, Rita Pereira, Ana Ferreira, Ruth Riisnaes, Daniel Nava Rodrigues, Juan M Jiménez-Vacas, Soojin Kim, Takuma Uo, Patrizio Di Micco, Anthony Tumber, Md Saiful Islam, Marc A Moesser, Martine Abboud, Akane Kawamura, Bora Gurel, 

A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer

一项恩扎卢胺联合AKT抑制剂AZD5363(capivasertib)治疗转移性去势抵抗性前列腺癌患者的I期剂量递增研究

Kolinsky, M P; Rescigno, P; Bianchini, D; Zafeiriou, Z; Mehra, N; Mateo, J; Michalarea, V; Riisnaes, R; Crespo, M; Figueiredo, I; Miranda, S; Nava Rodrigues, D; Flohr, P; Tunariu, N; Banerji, U; Ruddle, R; Sharp, A; Welti, J; Lambros, M; Carreira, S; Raynaud, F I; Swales, K E; Plymate, S; Luo, J; Tovey, H; Porta, N; Slade, R; Leonard, L; Hall, E; de Bono, J S

Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors

首创 ATR 抑制剂 M6620 (VX-970) 作为单一疗法或与卡铂联合治疗晚期实体瘤患者的 I 期临床试验

Timothy A Yap, Brent O'Carrigan, Marina S Penney, Joline S Lim, Jessica S Brown, Maria J de Miguel Luken, Nina Tunariu, Raquel Perez-Lopez, Daniel Nava Rodrigues, Ruth Riisnaes, Ines Figueiredo, Suzanne Carreira, Brian Hare, Katherine McDermott, Saira Khalique, Chris T Williamson, Rachael Natrajan, 

Genomics of lethal prostate cancer at diagnosis and castration resistance

诊断时致命性前列腺癌的基因组学及去势抵抗

Mateo, Joaquin; Seed, George; Bertan, Claudia; Rescigno, Pasquale; Dolling, David; Figueiredo, Ines; Miranda, Susana; Nava Rodrigues, Daniel; Gurel, Bora; Clarke, Matthew; Atkin, Mark; Chandler, Rob; Messina, Carlo; Sumanasuriya, Semini; Bianchini, Diletta; Barrero, Maialen; Petermolo, Antonella; Zafeiriou, Zafeiris; Fontes, Mariane; Perez-Lopez, Raquel; Tunariu, Nina; Fulton, Ben; Jones, Robert; McGovern, Ursula; Ralph, Christy; Varughese, Mohini; Parikh, Omi; Jain, Suneil; Elliott, Tony; Sandhu, Shahneen; Porta, Nuria; Hall, Emma; Yuan, Wei; Carreira, Suzanne; de Bono, Johann S

CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo

CDCP1 过表达驱动前列腺癌进展,并可作为体内治疗靶点。

Abdullah Alajati,Mariantonietta D'Ambrosio ,Martina Troiani,Simone Mosole,Laura Pellegrini,Jingjing Chen ,Ajinkya Revandkar ,Marco Bolis,Jean-Philippe Theurillat,Ilaria Guccini,Marco Losa,Arianna Calcinotto,Gaston De Bernardis,Emiliano Pasquini,Rocco D'Antuono,Adam Sharp,Ines Figueiredo ,Daniel Nava Rodrigues ,Jonathan Welti ,Veronica Gil ,Wei Yuan ,Tatjana Vlajnic,Lukas Bubendorf,Giovanna Chiorino,Letizia Gnetti,Verónica Torrano ,Arkaitz Carracedo   ,Laura Camplese,Susumu Hirabayashi,Elena Canato,Gianfranco Pasut,Monica Montopoli,Jan Hendrik Rüschoff,Peter Wild,Holger Moch,Johann De Bono ,Andrea Alimonti

Diverse AR Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer

多种 AR 基因重排介导转移性前列腺癌对雄激素受体抑制剂的耐药性

Yingming Li, Rendong Yang, Christine M Henzler, Yeung Ho, Courtney Passow, Benjamin Auch, Suzanne Carreira, Daniel Nava Rodrigues, Claudia Bertan, Tae Hyun Hwang, David A Quigley, Ha X Dang, Colm Morrissey, Michael Fraser, Stephen R Plymate, Christopher A Maher, Felix Y Feng, Johann S de Bono, Scott